CAPRICOR THERAPEUTICS INC. - COMMON STOCK

Capricor Therapeutics Announces Positive Type-B Meeting with FDA for CAP-1002 Program for Duchenne Muscular Dystrophy

24 4 2024 08:00:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics to Present at Upcoming Investor Conferences

21 3 2024 07:30:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Presents at 2024 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference

06 3 2024 07:30:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

29 2 2024 15:05:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Announces Upcoming Type-B Meeting with the FDA to Discuss Commercial Manufacturing Planning with an Aim to Expedite BLA Pathway for CAP-1002 in Duchenne Muscular Dystrophy

27 2 2024 07:30:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics to Present Fourth Quarter and Full Year 2023 Financial Results and Recent Corporate Update on February 29

22 2 2024 07:30:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Announces Manufacturing Scale-Up of CAP-1002 Production at New San Diego Facility as it Continues Plans Toward Commercialization

20 2 2024 07:30:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Announces Collaboration with the National Institutes of Health for Clinical Trial of Novel Exosome-Based Multivalent Vaccine for SARS-CoV-2

24 1 2024 08:15:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Announces Continuation of Phase 3 HOPE-3 Trial of CAP-1002 in Duchenne Muscular Dystrophy Based on Completion of Interim Futility Analysis

11 12 2023 08:00:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

14 11 2023 15:05:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

10 11 2023 09:26:11 提供 NetDania Notify

Capricor Therapeutics to Present Third Quarter 2023 Financial Results and Recent Corporate Update on November 14

07 11 2023 08:15:00 提供 Nasdaq GlobeNewswire

Capricor Therapeutics and Parent Project Muscular Dystrophy to Host Webinar to Review Latest Developments of CAP-1002 Program

19 10 2023 15:01:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

19 10 2023 09:26:51 提供 NetDania Notify

Capricor Therapeutics Announces Late-Breaking Presentations at 28th Annual Congress of the World Muscle Society

10 10 2023 08:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months Low: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

09 10 2023 12:23:58 提供 NetDania Notify

NetDania - New 12 months Low: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

05 10 2023 12:33:04 提供 NetDania Notify

NetDania - New 12 months Low: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

03 10 2023 09:14:58 提供 NetDania Notify

NetDania - New 12 months Low: CAPRICOR THERAPEUTICS INC. - COMMON STOCK

02 10 2023 09:36:32 提供 NetDania Notify

Capricor Therapeutics Announces $23 Million Registered Direct Offering

29 9 2023 06:35:51 提供 Nasdaq GlobeNewswire